This summer has been a busy one in the patent industry, with news of auctions and acquisitions grabbing headlines on a seemingly daily basis. As a company in the business of invention, we’ve also been paying close attention to the latest news from the scientific community, and we wanted to share some of this month’s highlights, including a piece from our own CEO.
In his monthly guest column for Bloomberg, IV CEO Nathan Myhrvold explores how human societies behave like slime mold, a colony of microorganisms which band together and act as a single, larger organism.
Meanwhile, Fortune’s Richard Martin analyzes how this year’s tragic Fukushima nuclear disaster may prompt governments and research institutions to invest in next-generation nuclear technologies like TerraPower’s traveling wave reactor.
Finally, the folks at IV’s Lab have been reading a piece in The Scientist on a recent breakthrough in skin technology. The epidermal electronic system (EES) is a tiny set of circuits applied to the skin like a temporary tattoo, and could one day allow humans to control machines through simple, natural muscle movements.